Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 12:22 AM
Ignite Modification Date:
2025-12-25 @ 10:26 PM
NCT ID:
NCT00485758
Group ID:
EG000
Title:
Extended Release Niacin/Laropiprant
Description:
One tablet of Extended Release Niacin/Laropiprant (1 gram/20 milligram) in addition to lipid modifying therapy. After 4 weeks, advanced to Extended Release Niacin/Laropiprant (2 gram/40 milligram).
No adjustments were made to any lipid modifying regimen established during run-in until Week 12.
Deaths Number Affected:
None
Deaths Number At Risk:
None
Serious Number Affected:
26
Serious Number At Risk:
449
Other Number Affected:
251
Other Number At Risk:
449
Study:
NCT00485758
Results Section:
NCT00485758
Adverse Events Module:
NCT00485758